Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients
Launched by UNIVERSITY HOSPITAL, ANGERS · Jan 29, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to help people with Huntington's disease (HD) improve their thinking, movement, and behavior. Huntington's disease is a genetic condition that usually appears in middle age and causes problems with movement, memory, and emotions. Since there isn't a cure for HD, researchers are exploring new methods to help manage symptoms. In this study, they will compare a program that combines physical exercise and mental challenges (called exergames) with a more traditional step-by-step approach to treatment.
To be part of this trial, participants need to be adults who have been diagnosed with early stages of Huntington's disease and meet certain health criteria. They should be able to understand the study and provide consent. Participants can expect to engage in activities that might help improve their quality of life, and the study aims to gather information on how effective these new approaches are. It's important to note that people with certain medical conditions or who are pregnant won't be able to participate. The trial is not yet recruiting, but it represents an exciting opportunity to explore new ways to support individuals living with Huntington's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults at inclusion
- • Huntington's disease diagnosed and confirmed by genetic analysis
- • Patient with stage 1-2 HD with a motor UHDRS score ≥ 5 and a CFT between 6 \< CFT ≤ 13
- • Patient with written informed consent or third-party consent
- • Affiliated or beneficiary of a social security scheme
- Exclusion Criteria:
- • Poor understanding of the French language
- • Participation in interventional research modifying management
- • History likely to interfere with cognition (established stroke, sequelae of traumatic brain injury, active epilepsy, learning disorders, alcohol dependence syndrome, drug use, psychiatric disorders), severe cognitive deficit (MMSE \<16), clinically significant pathological condition which, in the investigator's opinion, could interfere with the subject's safety or the evaluation of study results
- • Pregnant or breast-feeding women
- • Persons deprived of their liberty by administrative or judicial decision
- • Persons under compulsory psychiatric care
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anngers, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported